Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2.

Pymm, Phillip; Redmond, Samuel J; Dolezal, Olan; Mordant, Francesca; Lopez, Ester; Cooney, James P; Davidson, Kathryn C; Haycroft, Ebene R; Tan, Chee Wah; Seneviratna, Rebecca; Grimley, Samantha L; Purcell, Damian F J; Kent, Stephen J; Wheatley, Adam K; Wang, Lin-Fa; Leis, Andrew; Glukhova, Alisa; Pellegrini, Marc; Chung, Amy W; Subbarao, Kanta; Uldrich, Adam P; Tham, Wai-Hong; Godfrey, Dale I; Gherardin, Nicholas A

Pymm, Phillip; Redmond, Samuel J; Dolezal, Olan; Mordant, Francesca; Lopez, Ester; Cooney, James P; Davidson, Kathryn C; Haycroft, Ebene R; Tan, Chee Wah; Seneviratna, Rebecca; Grimley, Samantha L; Purcell, Damian F J; Kent, Stephen J; Wheatley, Adam K; Wang, Lin-Fa; Leis, Andrew; Glukhova, Alisa; Pellegrini, Marc; Chung, Amy W; Subbarao, Kanta; Uldrich, Adam P; Tham, Wai-Hong; Godfrey, Dale I; Gherardin, Nicholas A.

Pymm P; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Redmond SJ; Department of Medical Biology, University of Melbourne, Melbourne, VIC 3010, Australia.
Dolezal O; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC 3000, Australia.
Mordant F; Commonwealth Scientific and Industrial Research Organisation (CSIRO) Biomedical Program, Clayton, VIC 3168, Australia.
Lopez E; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC 3000, Australia.
Cooney JP; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC 3000, Australia.
Davidson KC; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Haycroft ER; Department of Medical Biology, University of Melbourne, Melbourne, VIC 3010, Australia.
Tan CW; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Seneviratna R; Department of Medical Biology, University of Melbourne, Melbourne, VIC 3010, Australia.
Grimley SL; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC 3000, Australia.
Purcell DFJ; Programme in Emerging Infectious Diseases, Duke NUS Medical School, Singapore 169857, Singapore.
Kent SJ; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC 3000, Australia.
Wheatley AK; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC 3000, Australia.
Wang LF; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC 3000, Australia.
Leis A; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC 3000, Australia.
Glukhova A; Australian Research Council Centre for Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Melbourne VIC 3010, Australia.
Pellegrini M; Department of Microbiology & Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC 3000, Australia.
Chung AW; Programme in Emerging Infectious Diseases, Duke NUS Medical School, Singapore 169857, Singapore.
Subbarao K; Programme in Emerging Infectious Diseases, Duke NUS Medical School, Singapore 169857, Singapore.
Uldrich AP; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Tham WH; The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.
Godfrey DI; Department of Medical Biology, University of Melbourne, Melbourne, VIC 3010, Australia.
Gherardin NA; Drug Discovery Biology, Monash Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville 3052 VIC, Australia.